1. | BioElectrics007 | |
2. | dsrjane | |
3. | ItsNewman | |
4. | SaulGoodman | |
5. | JasonJohnJacobs |
1. | BioElectrics007 | |
2. | dsrjane | |
3. | ItsNewman | |
4. | SaulGoodman | |
5. | JasonJohnJacobs |
1. | SaulGoodman 03/09/2018 SunTrust Robinson Humphrey raises PT to $40 |
2. | JasonJohnJacobs 07/24/2018 MRTX to present updated data from two studies on sitravatinib |
3. | BioElectrics007 09/24/2017 Our money counterparts and ventures will be adequate meet our expected commitments for no less than 1 year... Ought to be set for cash.... descent job by timing it with next week's abstract if done |
4. | ItsNewman 09/24/2017 May be heavily shorted on Monday to get it below that mark.... |
5. | ItsNewman 01/08/2018 We have news - BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region |
6. | BioElectrics007 09/24/2017 Ended at the opening from the big gap |
7. | ItsNewman 03/05/2018 Well... |
8. | dsrjane 03/05/2018 Looking hopeful |
9. | llttrusb1a60o2 03/05/2018 $50 |
10. | SaulGoodman 03/12/2018 Barclays initiates as an overweight, $44PT |